PAGLIARO, LUCA
 Distribuzione geografica
Continente #
EU - Europa 410
NA - Nord America 299
AS - Asia 139
AF - Africa 6
OC - Oceania 1
SA - Sud America 1
Totale 856
Nazione #
US - Stati Uniti d'America 291
IT - Italia 236
SG - Singapore 72
CN - Cina 56
IE - Irlanda 37
AT - Austria 28
SE - Svezia 23
DE - Germania 21
FI - Finlandia 14
FR - Francia 9
BE - Belgio 8
GB - Regno Unito 7
NL - Olanda 7
CZ - Repubblica Ceca 5
RU - Federazione Russa 5
CA - Canada 4
CI - Costa d'Avorio 4
IN - India 4
PA - Panama 4
JP - Giappone 3
ES - Italia 2
GR - Grecia 2
LT - Lituania 2
TR - Turchia 2
AU - Australia 1
EG - Egitto 1
HK - Hong Kong 1
IL - Israele 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 856
Città #
Parma 74
Singapore 64
Santa Clara 44
Boardman 40
Dublin 37
Ann Arbor 33
Ashburn 33
Chandler 27
Vienna 26
Shanghai 25
Milan 20
Bologna 11
Helsinki 10
Brescia 9
Carpi 8
New York 8
Perugia 8
West Jordan 8
Brussels 7
Dallas 7
Modena 7
Chicago 6
Rome 6
Amsterdam 5
Abidjan 4
Beijing 4
Bremen 4
Brno 4
Frankfurt am Main 4
Nanjing 4
Princeton 4
Reggio Emilia 4
Turin 4
Munich 3
Rovereto 3
Wilmington 3
Athens 2
Boretto 2
Chengdu 2
Cordovado 2
Cosenza 2
Falls Church 2
Fidenza 2
Inglewood 2
Jinan 2
Kochi 2
Kunming 2
Leytonstone 2
Massarosa 2
Münster 2
Orzinuovi 2
Ottawa 2
Padova 2
Paris 2
Pescara 2
Sassuolo 2
Vigevano 2
Woodbridge 2
Zhengzhou 2
Bentivoglio 1
Bhubaneswar 1
Bratislava 1
Cairo 1
Catania 1
Cedar Knolls 1
Cheyenne 1
Cornaredo 1
Dearborn 1
Des Moines 1
Esslingen am Neckar 1
Fairfield 1
Falkenstein 1
Fremont 1
Genova 1
Ghent 1
Grafing 1
Guangzhou 1
Hebei 1
Houston 1
Istanbul 1
Izmir 1
Kaifeng 1
Lima 1
Los Angeles 1
Mezzolombardo 1
Mianyang 1
Montreal 1
Moscow 1
Nanchang 1
Naples 1
Neviano degli Arduini 1
Ortona 1
Oslo 1
Pune 1
Redwood City 1
Rho 1
Riga 1
San Mateo 1
Seattle 1
Segrate 1
Totale 655
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 119
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 117
Targeting oncogenic Notch signaling with SERCA inhibitors 113
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 85
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 56
Targeting Notch Trafficking and Processing in Cancers 54
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 47
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis 39
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 32
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL 31
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 28
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine 26
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 22
Acute lymphoblastic leukaemia 22
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 20
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 17
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 16
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 16
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 15
FROM GENOMICS TO CHEMOGEGNOMICS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA 12
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia 11
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 10
Totale 908
Categoria #
all - tutte 4.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 4 3 0 0 4 0 3
2020/202184 1 1 2 11 11 5 1 11 11 16 4 10
2021/202251 3 4 6 4 3 4 11 3 1 3 2 7
2022/2023166 8 19 12 11 31 14 5 7 36 2 17 4
2023/2024259 8 3 4 15 5 18 70 22 14 33 17 50
2024/2025313 33 37 55 81 84 23 0 0 0 0 0 0
Totale 908